ConductScience.org, home

Paper623398

Theophylline bioavailability following oral administration of six sustained-release preparations.

Spangler DL and 3 others. Ann Allergy, 1978. Cited by 127 papers, by iCite.

Cite this record

ConductScience Library. Theophylline bioavailability following oral administration of six sustained-release preparations. Papers, record 623398. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/623398

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Theophylline bioavailability following oral administration of six sustained-release preparations.
PubMed
Journal
Ann Allergy
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
127
iCite
Relative citation ratio, by iCite
9.1
iCite
Revised in PubMed
2013-11-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Spangler DLD L
2Kalof DDD D
3Bloom FLF L
4Wittig HJH J

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
TheophyllineMajor topic
Administration, Oral
Adult
Biological Availability
Delayed-Action Preparations
Drug Evaluation
Humans
Male
Middle Aged
Nausea
Tachycardia, Paroxysmal
Tremor

Source PubMed

Download CSV of topics

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 127 citations.

PMIDTitleJournalYearIn PapersSource
8005187Kinetic interaction between theophylline and a newly developed anti-allergic drug, pemirolast potassium.Eur J Clin Pharmacol1994https://conductscience.org/library/papers/8005187PubMed
7431220Evaluation of the absorption from some commercial enteric-release theophylline products.J Pharmacokinet Biopharm1980https://conductscience.org/library/papers/7431220PubMed
7431219Evaluation of the absorption from some commercial sustained-release theophylline products.J Pharmacokinet Biopharm1980https://conductscience.org/library/papers/7431219PubMed
7420268Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria.J Pharmacokinet Biopharm1980https://conductscience.org/library/papers/7420268PubMed
7042294Rate-controlled drug dosage.Drugs1982https://conductscience.org/library/papers/7042294PubMed
6866717In vitro testing of controlled release theophylline preparations: Theolair, Theograd and Theolin.Pharm Weekbl Sci1983https://conductscience.org/library/papers/6866717PubMed
6840168Sustained serum theophylline concentrations during chronic twice daily administration of a slow release preparation.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6840168PubMed
6832206Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6832206PubMed
6783231Combined treatment with sustained-release theophylline and beta2-adrenoceptor-stimulating agents in chronic childhood asthma.Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6783231PubMed
6760111A double-blind comparative trial between two sustained-release theophylline preparations with individual doses in asthmatic in-patients.Pharm Weekbl Sci1982https://conductscience.org/library/papers/6760111PubMed
6734702Comparative pharmacokinetic analysis of a novel sustained-release dosage form of theophylline in humans.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6734702PubMed
6686557Bioavailability and diurnal variation in absorption of sustained release theophylline in asthmatic children.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6686557PubMed
6439357Slow release theophyllines and chronic bronchitis.Br Med J (Clin Res Ed)1984https://conductscience.org/library/papers/6439357PubMed
6370542A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.Clin Pharmacokinet1984https://conductscience.org/library/papers/6370542PubMed
6131723New drugs in respiratory disorders: I.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6131723PubMed
3982951Food and a sustained release theophylline tablet on chronic dosing: bioavailability, peak-trough and trough-trough differences.Pharm Weekbl Sci1985https://conductscience.org/library/papers/3982951PubMed
3834072New method for bioavailability assessment of slow-release preparations of theophylline.J Pharmacokinet Biopharm1985https://conductscience.org/library/papers/3834072PubMed
3790407The effect of age on theophylline clearance in normal subjects.Br J Clin Pharmacol1986https://conductscience.org/library/papers/3790407PubMed
3508547Computer-aided dosage form design. II. Methods for defining a zero-order sustained-release delivery system of maximum formulating flexibility.Pharm Res1987https://conductscience.org/library/papers/3508547PubMed
3315687A once daily theophylline preparation in prevention of nocturnal symptoms in childhood asthma.Eur J Pediatr1987https://conductscience.org/library/papers/3315687PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/623398

GET https://conductscience.org/api/papers/v1/623398/cited_by?page=2